Shin Poong announces British NICE’s recommendation on Inisia Tab as primary therapy
Shin Poong Pharm(CEO Jae-Man Yoo) announced the National Institute for Health and Clinical Excellence(NICE), a drug cost-efficacy assessment agency under the British government, recommended the national health insurance benefit of the world’s first fibroids treatment ‘Inisia Tab(generic name: uli...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
